Literature DB >> 31245140

Terlipressin as a first choice in septic shock-not yet.

Daniel Lima Rocha1, Fabio Tanzillo Moreira1, Ary Serpa Neto1,2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31245140      PMCID： PMC6560539          DOI： 10.21037/jtd.2019.03.49

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  15 in total

1.  A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.

Authors:  Ashok Choudhury; Chandan K Kedarisetty; Chitranshu Vashishtha; Deepak Saini; Sachin Kumar; Rakhi Maiwall; Manoj K Sharma; Ajeet S Bhadoria; Guresh Kumar; Yogendra K Joshi; Shiv K Sarin
Journal:  Liver Int       Date:  2016-10-20       Impact factor: 5.828

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 3.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

4.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Authors:  Anthony C Gordon; Alexina J Mason; Neeraja Thirunavukkarasu; Gavin D Perkins; Maurizio Cecconi; Magda Cepkova; David G Pogson; Hollmann D Aya; Aisha Anjum; Gregory J Frazier; Shalini Santhakumaran; Deborah Ashby; Stephen J Brett
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

Review 5.  Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum.

Authors:  Davide Tommaso Andreis; Mervyn Singer
Journal:  Intensive Care Med       Date:  2016-02-12       Impact factor: 17.440

Review 6.  Vasopressors for hypotensive shock.

Authors:  Gunnar Gamper; Christof Havel; Jasmin Arrich; Heidrun Losert; Nathan Leon Pace; Marcus Müllner; Harald Herkner
Journal:  Cochrane Database Syst Rev       Date:  2016-02-15

7.  Terlipressin in catecholamine-resistant septic shock patients.

Authors:  Marc Leone; Jacques Albanèse; Anne Delmas; Wajdi Chaabane; Franck Garnier; Claude Martin
Journal:  Shock       Date:  2004-10       Impact factor: 3.454

8.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 9.  Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.

Authors:  Tomer Avni; Adi Lador; Shaul Lev; Leonard Leibovici; Mical Paul; Alon Grossman
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

Review 10.  Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.

Authors:  Ary Serpa Neto; Antônio P Nassar; Sérgio O Cardoso; José A Manetta; Victor G M Pereira; Daniel C Espósito; Maria C T Damasceno; James A Russell
Journal:  Crit Care       Date:  2012-08-14       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.